GlassScriptPhysician profile
Ana Marie Antonetti
NPI 1427319821
$1,377.51
in general payments reported to CMS, 2019-2025
20 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2022: $37.96 · 2023: $453 · 2024: $289 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $493 · Education: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $493.36 |
| Education | $387.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $678.94 | 2019-2025 | Veozah |
| Abbvie INC. | $101.24 | 2019-2023 | Orilissa, Lo Loestrin Fe, Oriahnn |
| Bayer Healthcare Pharmaceuticals INC. | $79.17 | 2019-2025 | |
| Pfizer INC. | $72.76 | 2019 | |
| Exeltis, USA INC. | $68.72 | 2019-2025 | Slynd |
| Organon LLC | $64.30 | 2023-2025 | Nexplanon |
| Amag Pharmaceuticals, INC. | $58.55 | 2019 | |
| Therapeuticsmd, INC. | $36.02 | 2019 | |
| Sumitomo Pharma America, INC. | $31.57 | 2023-2025 | Myfembree |
| Coopersurgical, INC. | $26.76 | 2023 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $22.87 | 2023 | |
| Avion Pharmaceuticals | $21.99 | 2019 | |
| Millicent US INC | $19.68 | 2019 | |
| Sage Therapeutics, LLC | $14.59 | 2024 | |
| Duchesnay USA Incorporated | $14.44 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $14.24 | 2022 | |
| Boston Scientific Corporation | $14.13 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.29 | 2019 | |
| Lupin INC. | $12.25 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ana Antonetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.